Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nicola Di Renzo, Maura Brugiatelli, Antonella Montanini, Maria Luigia Vigliotti, Giulia Cervetti, Anna Marina Liberati, Stefano Luminari, Pierangelo Spedini, Gianfranco Giglio & Massimo Federico. (2006) Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi. Leukemia & Lymphoma 47:3, pages 473-479.
Read now
Read now
Articles from other publishers (24)
Kavitha Ramaswamy, Peter G. SteinherzAnurag K. Agrawal, Christopher J. ForlenzaAudrey Mauguen, Mikhail Roshal, Tanya TrippettNancy A. KernanMaria Luisa SulisNeerav Shukla. (2022) Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML. Blood Advances 6:8, pages 2688-2694.
Crossref
Crossref
Barthelemy Diouf, Claudia Wing, John C. Panetta, Donnie Eddins, Wenwei Lin, Wenjian Yang, Yiping Fan, Deqing Pei, Cheng Cheng, Shannon M. Delaney, Wei Zhang, Erik J. Bonten, Kristine R. Crews, Steven W. Paugh, Lie Li, Burgess B. Freeman3rd3rd, Robert J. Autry, Jordan A. Beard, Daniel C. Ferguson, Laura J. Janke, Kirsten K. Ness, Taosheng Chen, Stanislav S. Zakharenko, Sima Jeha, Ching‐Hon Pui, Mary V. Relling, M. Eileen Dolan & William E. Evans. (2021) Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine. Clinical and Translational Science 14:4, pages 1490-1504.
Crossref
Crossref
Tai Rao, Zhirong Tan, Jingbo Peng, Ying Guo, Yao Chen, Honghao Zhou & Dongsheng Ouyang. (2019) The pharmacogenetics of natural products: A pharmacokinetic and pharmacodynamic perspective. Pharmacological Research 146, pages 104283.
Crossref
Crossref
Beatrice Mueller, Katja Seipel, Ulrike Bacher & Thomas Pabst. (2018) Autologous Transplantation for Older Adults with AML. Cancers 10:9, pages 340.
Crossref
Crossref
Marko Kavcic, Blaz Koritnik, Matevz Krzan, Orjana Velikonja, Tomaz Prelog, Milica Stefanovic, Maruša Debeljak & Janez Jazbec. (2017) Electrophysiological Studies to Detect Peripheral Neuropathy in Children Treated With Vincristine. Journal of Pediatric Hematology/Oncology 39:4, pages 266-271.
Crossref
Crossref
W Stock, B Diouf, KR Crews, D Pei, C Cheng, K Laumann, SJ Mandrekar, S Luger, A Advani, RM Stone, RA Larson & WE Evans. (2017)
An Inherited Genetic Variant in
CEP72
Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia
. Clinical Pharmacology & Therapeutics 101:3, pages 391-395.
Crossref
Crossref
Wei-Hsin Chiu, Sheng-Jei Luo, Chia-Ling Chen, Jai-Hong Cheng, Chia-Yuan Hsieh, Chi-Yun Wang, Wei-Ching Huang, Wu-Chou Su & Chiou-Feng Lin. (2012) Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells. Biochemical Pharmacology 83:9, pages 1159-1171.
Crossref
Crossref
David W. Dougherty & Jonathan W. Friedberg. (2010) Gemcitabine and Other New Cytotoxic Drugs: Will Any Find Their Way Into Primary Therapy?. Current Hematologic Malignancy Reports 5:3, pages 148-156.
Crossref
Crossref
Takaaki Yamada, Nobuaki Egashira, Maiko Imuta, Takahisa Yano, Yui Yamauchi, Hiroyuki Watanabe & Ryozo Oishi. (2010) Role of oxidative stress in vinorelbine-induced vascular endothelial cell injury. Free Radical Biology and Medicine 48:1, pages 120-127.
Crossref
Crossref
Mohamad M Al-RahawanPedro A de Alarcón. (2009) Gemcitabine and vinorelbine therapy for patients with Hodgkin lymphoma. Pediatric Health 3:6, pages 525-532.
Crossref
Crossref
Peter D. ColeCindy L. SchwartzRichard A. DrachtmanPedro A. de AlarconLu ChenTanya M. Trippett. (2009) Phase II Study of Weekly Gemcitabine and Vinorelbine for Children With Recurrent or Refractory Hodgkin's Disease: A Children's Oncology Group Report. Journal of Clinical Oncology 27:9, pages 1456-1461.
Crossref
Crossref
Diane Braguer, Jean-Marc Barret, Hayley McDaid & Anna Kruczynski. (2008) Antitumor Activity of Vinflunine: Effector Pathways and Potential for Synergies. Seminars in Oncology 35, pages S13-S21.
Crossref
Crossref
Anne Zuse, Helge Prinz, Klaus Müller, Peter Schmidt, Eckhard G. Günther, Frank Schweizer, Jochen H.M. Prehn & Marek Los. (2007) 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones and benzylidene-9(10H)-anthracenones as novel tubulin interacting agents with high apoptosis-inducing activity. European Journal of Pharmacology 575:1-3, pages 34-45.
Crossref
Crossref
Gulacti Topcu & Ayhan Ulubelen. (2007) Structure elucidation of organic compounds from natural sources using 1D and 2D NMR techniques. Journal of Molecular Structure 834-836, pages 57-73.
Crossref
Crossref
T. M. Trippett & A. Chen. 2007. Pediatric Lymphomas. Pediatric Lymphomas
67
84
.
Fatih M. Uckun, Sanda Morar & Sanjive Qazi. (2006) Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias. British Journal of Haematology 135:4, pages 500-508.
Crossref
Crossref
Mei Zhang, Michael Boyer, Laurent Rivory, Angela Hong, Stephen Clarke, Graham Stevens & Kate Fife. (2004) Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non–small-cell lung cancer cells. International Journal of Radiation Oncology*Biology*Physics 58:2, pages 353-360.
Crossref
Crossref
E A Kolb & P G Steinherz. (2003) A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia. Leukemia 17:10, pages 1967-1972.
Crossref
Crossref
Naoya Ochiai, Chihiro Shimazaki, Tohru Inaba, Shin-ichi Fuchida, Akira Okano, Mayumi Hatsuse, Hideyo Hirai, Eishi Ashihara, Naohisa Fujita & Masao Nakagawa. (2002) Effect of vinorelbine on the growth of human myeloma cell lines in vitro. Leukemia Research 26:8, pages 731-738.
Crossref
Crossref
A Kruczynski, C Etiévant, D Perrin, N Chansard, A Duflos & B T Hill. (2002) Characterization of cell death induced by vinflunine, the most recent Vinca alkaloid in clinical development. British Journal of Cancer 86:1, pages 143-150.
Crossref
Crossref
M.S. Aapro, P. Harper, S.A. Johnson & J.B. Vermorken. (2001) Developments in cytotoxic chemotherapy: advances in treatment utilising vinorelbine. Critical Reviews in Oncology/Hematology 40:3, pages 251-263.
Crossref
Crossref
James E Fortney, Wei Zhao, Sharon L Wenger & Laura F Gibson. (2001) Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy. Leukemia Research 25:10, pages 901-907.
Crossref
Crossref
R.D. Bonfil, A.D. Gonzalez, D. Siguelboim, F.D. Cuello Carrion, D.R. Ciocca, A. Villaronga, L. Metz, F. Mosso, E. Fayad, M. Reale & A.J. Schmilovich. (2001)
Immunohistochemical analysis of Ki-67, p21
waf1/cip1
and apoptosis in marker lesions from patients with superficial bladder tumours treated with vinorelbine intravesical therapy in a preliminary phase I trial
. BJU International 88:4, pages 425-431.
Crossref
Crossref
I. Genvresse, B. Flath, K. Akrivakis, T. Beinert, E. Späth-Schwalbe & K. Possinger. (2000) Resolution of psoriatic skin lesions after chemotherapy with gemcitabine and vinorelbine. British Journal of Dermatology 143:6, pages 1326-1327.
Crossref
Crossref